Junli Duan

Dr. Junli Duan

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2018 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
JQJia Qi
Jia Qi
FWFeng Wang
Feng Wang
PYPing Yang
Ping Yang
XWXuelian Wang
Xuelian Wang
RXRenjie Xu
Renjie Xu
JDJunli Duan
Junli Duan
Hypertension-induced cardiac apoptosis is a major contributor to early-stage heart-failure. Our previous studies have found that p53-mediated mitochondrial fission is involved in aldosterone-induced podocyte apoptosis. However, it is not clear that whether p53-induced mitochondrial fission is critical for hypertensive Angiotensin II (AngII)-induced cardiomyocyte apoptosis. In this study, we found that inhibition of the mitochondrial fission protein Drp1 (dynamin-related protein 1) by Mdivi-1 prevented cardiomyocyte apoptosis and cardiac remodeling in SHRs. In vitro we found that treatment of cultured neonatal rat cardiomyocytes with AngII induced Drp1 expression, mitochondrial fission, and apoptosis. Knockdown of Drp1 inhibited AngII-induced mitochondrial fission and cardiomyocyte apoptosis. Furthermore, AngII induced p53 acetylation. Knockdown of p53 inhibited AngII-induced Drp1 expression, mitochondrial fission, and cardiomyocyte apoptosis. Besides, we found that Sirt1 was able to reverse AngII-induced p53 acetylation and its binding to the Drp1 promoter, which subsequently inhibited mitochondrial fission and eventually attenuated cardiomyocyte apoptosis. Collectively, these results suggest that AngII degrades Sirt1 to increase p53 acetylation, which induces Drp1 expression and eventually results in cardiomyocyte apoptosis. Sirt1/p53/Drp1dependent mitochondrial fission may be a valuable therapeutic target for hypertension induced heart failure.

6 January 2021 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
GHGao-Jian Huang
Gao-Jian Huang
HYHan-Ping Yu
Han-Ping Yu
XWXue-Lian Wang
Xue-Lian Wang
BNBing-Bing Ning
Bing-Bing Ning
JGJing Gao
Jing Gao
JDJunli Duan
Junli Duan
Hydroxyapatite (HAP) is promising for the clinical treatment of bone defects because of its excellent biocompatibility and osteo-conductivity. However, highly porous HAP scaffolds usually exhibit high brittleness and poor mechanical properties, thus organic constituents are usually added to form composite materials. In this work, a highly porous and elastic aerogel made from ultralong HAP nanowires with ultrahigh porosity (∼98.5%), excellent elasticity and suitable porous structure is prepared as the high-performance scaffold for bone defect repair. The highly porous structure of the as-prepared aerogel is beneficial to bone ingrowth and matter/fluid transfer, and the high elasticity can ensure the structural integrity of the scaffold during bone regeneration. Therefore, the HAP nanowire aerogel scaffold can promote the adhesion, proliferation and migration of rat bone marrow derived mesenchymal stem cells (rBMSCs), and elevate the protein expression of osteogenesis and angiogenesis related genes. The in vivo experimental results demonstrate that the HAP nanowire aerogel scaffold is favorable for the ingrowth of new bone and blood vessels, and thus can greatly accelerate bone regeneration and neovascularization. The as-prepared HAP nanowire aerogel scaffold shows promising potential for biomedical applications such as bone defect repair.

1 April 2022 in Coatings
Verified
Journal Article
Open access
PDF file
JGJing Gao
Jing Gao
LHLiangshi Hao
Liangshi Hao
BNBing-Bing Ning
Bing-Bing Ning
YZyuankang zhu
yuankang zhu
JGJu-Bo Guan
Ju-Bo Guan
JDJunli Duan
Junli Duan
Skin injury that is difficult to heal caused by various factors remains a major clinical challenge. Hydroxyapatite (HAP) has high potential for wound healing owing to its high biocompatibility and adequate angiogenic ability, while traditional HAP materials are not suitable for wound dressing due to their high brittleness and poor mechanical properties. To address this challenge, we developed a novel wound dressing made of flexible ultralong HAP nanowire-based biopaper. This biopaper is flexible and superhydrophilic, with suitable tensile strength (2.57 MPa), high porosity (77%), and adequate specific surface area (36.84 m2·g−1) and can continuously release Ca2+ ions to promote the healing of skin wounds. Experiments in vitro and in vivo show that the ultralong HAP nanowire-based biopaper can effectively induce human umbilical vein endothelial cells (HUVECs) treated with hypoxia and rat skin tissue to produce more angiogenic factors. The as-prepared biopaper can also enhance the proliferation, migration, and in vitro angiogenesis of HUVECs. In addition, the biopaper can promote the rat skin to achieve thicker skin re-epithelialization and the formation of new blood vessels, and thus promote the healing of the wound. Therefore, the ultralong HAP nanowire-based biopaper has the potential to be a safe and effective wound dressing and has significant clinical application prospects.

26 November 2024 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
YZYuankang Zhu
Yuankang Zhu
LHLiangshi Hao
Liangshi Hao
YLYurui Luo
Yurui Luo
JGJing Gao
Jing Gao
FXFengming Xu
Fengming Xu
JDJunli Duan
Junli Duan
An acute wound is the most common type of skin injury. Developing wound dressings with excellent mechanical properties, wound protection, comfort, angiogenic capacity and therapeutic effects is significant for effective treatments, yet remains challenging. Herein, we have designed a novel HAP–Alg composite dressing comprising a complementary ultralong hydroxyapatite (HAP) nanowire bio-paper and calcium alginate hydrogel. The HAP bio-paper assembled by ultralong HAP nanowires, in contrast to typical brittle HAP bio-ceramics, exhibits a highly flexible and interwoven structure to enhance the mechanical and protective performance of an alginate hydrogel, and the alginate matrix creates a moist environment for skin regeneration. Therefore, the HAP–Alg composite dressing presents good mechanical properties and high resistance to swelling and shrinkage, along with a reliable bacterial shielding ability. In addition, its moisturizing effect can deliver bioactive calcium ions to promote angiogenesis, accelerate re-epithelialization and reduce scar formation. In vitro studies reveal that the HAP–Alg composite dressing has excellent biocompatibility, promotes cell migration and angiogenesis, and enhances calcium ion influx. In vivo wound models further prove the ability of the HAP–Alg composite dressing to accelerate wound closure, enhance collagen deposition, and induce neovascularization. This work demonstrates that the HAP–Alg composite dressing offers a promising wound dressing for acute wound treatment and protection.

16 May 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
LHLi Han
Li Han
GYGuoxin Ye
Guoxin Ye
WSWenjing Su
Wenjing Su
YZYuankang Zhu
Yuankang Zhu
WWWenqi Wu
Wenqi Wu
JDJunli Duan
Junli Duan
Recently, the vascular protective effect of anti-diabetic agents has been receiving much attention. Sodium glucose cotransporter 2 (SGLT2) inhibitors had demonstrated reductions in cardiovascular (CV) events. However, the therapeutic effect of dapagliflozin on angiogenesis in peripheral arterial disease was unclear. This study aimed to explore the effect and mechanism of dapagliflozin on angiogenesis after hindlimb ischemia. We first evaluated the effect of dapagliflozin on post-ischemic angiogenesis in the hindlimbs of rats. Laser doppler imaging was used to detect the hindlimb blood perfusion. In addition, we used immunohistochemistry to detect the density of new capillaries after ischemia. The relevant signaling pathways of dapagliflozin affecting post-ischemic angiogenesis were screened through phosphoproteomic detection, and then the mechanism of dapagliflozin affecting post-ischemic angiogenesis was verified at the level of human umbilical vein endothelial cells (HUVECs). After subjection to excision of the left femoral artery, all rats were randomly distributed into two groups: the dapagliflozin group (left femoral artery resection, receiving intragastric feeding with dapagliflozin (1 mg/kg/d), for 21 consecutive days) and the model group, that is, the positive control group (left femoral artery resection, receiving intragastric feeding with citric acid–sodium citrate buffer solution (1 mg/kg/d), for 21 consecutive days). In addition, the control group, that is the negative control group (without left femoral artery resection, receiving intragastric feeding with citric acid–sodium citrate buffer solution (1 mg/kg/d), for 21 consecutive days) was added. At day 21 post-surgery, the dapagliflozin-treatment group had the greatest blood perfusion, accompanied by elevated capillary density. The results showed that dapagliflozin could promote angiogenesis after hindlimb ischemia. Then, the ischemic hindlimb adductor-muscle tissue samples from three rats of model group and dapagliflozin group were taken for phosphoproteomic testing. The results showed that the PI3K-Akt-eNOS signaling pathway was closely related to the effect of dapagliflozin on post-ischemic angiogenesis. Our study intended to verify this mechanism from the perspective of endothelial cells. In vitro, dapagliflozin enhanced the tube formation, migration, and proliferation of HUVECs under ischemic and hypoxic conditions. Additionally, the dapagliflozin administration upregulated the expression of angiogenic factors phosphorylated Akt (p-Akt) and phosphorylated endothelial nitric oxide synthase (p-eNOS), as well as vascular endothelial growth factor A (VEGFA), both in vivo and in vitro. These benefits could be blocked by either phosphoinositide 3-kinase (PI3K) or eNOS inhibitor. dapagliflozin could promote angiogenesis after ischemia. This effect might be achieved by promoting the activation of the PI3K-Akt-eNOS signaling pathway. This study provided a new perspective, new ideas, and a theoretical basis for the treatment of peripheral arterial disease.

17 December 2024 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
YZYuankang Zhu
Yuankang Zhu
ZYZhenlin Yang
Zhenlin Yang
YCYuhao Chen
Yuhao Chen
LQLingzi Qian
Lingzi Qian
CHChangning Hao
Changning Hao
JDJunli Duan
Junli Duan
Glyphosate, as one of the most widely used herbicides worldwide, has been reclassified as a potential carcinogen and linked to multiple health problems. Recent data from animal experiments have proved its potential cardiovascular toxicity. However, whether glyphosate exposure influences human cardiovascular health at the population levels remains unknown. This study aims to elucidate the correlation between glyphosate exposure and Cardiovascular Health (CVH) by utilizing comprehensive Life's Essential 8 (LE8) metrics. Data from 2842 participants, approximating 155.24 million U.S. adults, from 2013 to 2018 in National Health and Nutrition Examination Survey were analyzed. The association between natural logarithm (ln)-transformed glyphosate exposure in urine and CVH was examined using weighted linear regression and restricted cubic spline (RCS) models. Mediation analysis was used to determine potential mediators correlated with glyphosate and CVH. Further subgroup analysis and sensitive analysis were conducted to confirm the results. In fully adjusted models, the total CVH score decreased by 1.33 points for every unit increase in continuous ln-transformed glyphosate [β = -1.33, 95 % confidence interval (CI) (-2.25, -0.41)]. There was a negative correlation between the total CVH score and the lowest quantiles of ln-transformed glyphosate (Q1), Q2, Q3, and Q4 with p for trend < 0.05. A non-linear relationship between glyphosate and total CVH emerged (p for non-linear<0.001, p for overall = 0.003), and no safe threshold of glyphosate was observed. Serum insulin was an important mediator in the adverse effects of glyphosate on CVH with an 18.73 % mediation proportion. Moreover, higher serum insulin levels and higher homeostasis model assessment of insulin resistance were associated with higher glyphosate exposure but negatively correlated with total CVH score. Glyphosate exposure may pose a risk to cardiovascular health at the population levels, with elevated serum insulin levels acting as a crucial mediating element. Further studies are required to investigate the safe threshold and underlying mechanism of glyphosate impairment.